Scarica l'app Stockscreener
252.87
0.96%
-2.45
Dopo l'orario di chiusura:
252.87
Panoramica
Notizia
Cronologia dei prezzi
Catena di opzioni
Financials
Perché RMD Giù?
Forum
Previsione
Frazionamento azionario
Storia dei dividendi
Precedente Chiudi:
$255.32
Aprire:
$253.15
Volume 24 ore:
917.66K
Relative Volume:
0.89
Capitalizzazione di mercato:
$36.84B
Reddito:
$5.40B
Utile/perdita netta:
$1.49B
Rapporto P/E:
25.00
EPS:
10.1168
Flusso di cassa netto:
$1.78B
1 W Prestazione:
-1.32%
1M Prestazione:
-6.91%
6M Prestazione:
-8.73%
1 anno Prestazione:
+12.37%
Intervallo 1D:
$248.13
$253.26
Intervallo di 1 settimana:
$248.13
$260.22
Portata 52W:
$199.92
$293.81
Resmed Inc Stock (RMD) Company Profile
Nome
Resmed Inc
Settore
Industria
Telefono
(858) 746-2400
Indirizzo
9001 SPECTRUM CENTER BLVD., SAN DIEGO, CA
Compare RMD vs ISRG, BDX, ALC, MDLN
| Azioni | Prezzo | Cap. di mercato | Reddito | Reddito netto | Flusso di cassa | EPS |
|---|---|---|---|---|---|---|
RMD
Resmed Inc
|
252.87 | 37.19B | 5.40B | 1.49B | 1.78B | 10.12 |
|
ISRG
Intuitive Surgical Inc
|
490.16 | 176.39B | 10.06B | 2.88B | 2.49B | 7.876 |
|
BDX
Becton Dickinson Co
|
167.12 | 48.34B | 21.92B | 1.76B | 2.63B | 6.1223 |
|
ALC
Alcon Inc
|
81.33 | 40.22B | 10.40B | 980.00M | 1.61B | 1.9749 |
|
MDLN
Medline Inc
|
43.83 | 35.75B | 28.43B | 1.16B | 1.26B | 1.4457 |
Resmed Inc Stock (RMD) Upgrades & Downgrades
| Data | Azione | Analista | Modifica della valutazione |
|---|---|---|---|
| 2025-12-16 | Downgrade | Robert W. Baird | Outperform → Neutral |
| 2025-09-18 | Iniziato | Citigroup | Buy |
| 2025-09-02 | Aggiornamento | CLSA | Hold → Outperform |
| 2025-07-15 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2025-03-19 | Iniziato | Morgan Stanley | Overweight |
| 2025-01-16 | Iniziato | Goldman | Buy |
| 2025-01-10 | Iniziato | Piper Sandler | Neutral |
| 2024-12-13 | Iniziato | Stifel | Hold |
| 2024-09-24 | Iniziato | Robert W. Baird | Outperform |
| 2024-09-18 | Downgrade | Wolfe Research | Peer Perform → Underperform |
| 2024-09-04 | Downgrade | Needham | Buy → Hold |
| 2024-06-25 | Downgrade | Oppenheimer | Outperform → Perform |
| 2024-06-24 | Downgrade | Citigroup | Buy → Neutral |
| 2024-02-06 | Ripresa | KeyBanc Capital Markets | Overweight |
| 2023-10-27 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2023-10-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2023-10-09 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2023-09-29 | Downgrade | Wolfe Research | Outperform → Peer Perform |
| 2023-09-06 | Aggiornamento | Needham | Hold → Buy |
| 2023-09-05 | Downgrade | UBS | Buy → Neutral |
| 2023-08-01 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2023-05-23 | Iniziato | UBS | Buy |
| 2023-04-14 | Iniziato | Mizuho | Buy |
| 2023-01-17 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-10-28 | Downgrade | Citigroup | Buy → Neutral |
| 2022-10-20 | Aggiornamento | BofA Securities | Neutral → Buy |
| 2022-10-12 | Iniziato | Jefferies | Hold |
| 2022-09-08 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-08-15 | Downgrade | CLSA | Buy → Outperform |
| 2022-08-12 | Downgrade | Citigroup | Buy → Neutral |
| 2022-08-12 | Downgrade | JP Morgan | Overweight → Neutral |
| 2022-08-12 | Downgrade | RBC Capital Mkts | Outperform → Sector Perform |
| 2022-06-06 | Aggiornamento | RBC Capital Mkts | Sector Perform → Outperform |
| 2022-04-06 | Iniziato | Wolfe Research | Outperform |
| 2022-01-31 | Aggiornamento | Citigroup | Neutral → Buy |
| 2022-01-31 | Aggiornamento | Goldman | Neutral → Buy |
| 2022-01-28 | Aggiornamento | RBC Capital Mkts | Underperform → Sector Perform |
| 2022-01-24 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2022-01-24 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2022-01-13 | Aggiornamento | CLSA | Outperform → Buy |
| 2022-01-13 | Aggiornamento | Robert W. Baird | Neutral → Outperform |
| 2021-12-21 | Aggiornamento | KeyBanc Capital Markets | Sector Weight → Overweight |
| 2021-12-06 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-10-22 | Aggiornamento | CLSA | Underperform → Outperform |
| 2021-08-02 | Downgrade | CLSA | Outperform → Sell |
| 2021-08-02 | Downgrade | Needham | Buy → Hold |
| 2021-07-28 | Aggiornamento | Jefferies | Underperform → Hold |
| 2021-07-26 | Downgrade | JP Morgan | Overweight → Neutral |
| 2021-07-14 | Iniziato | RBC Capital Mkts | Underperform |
| 2021-06-28 | Downgrade | Citigroup | Buy → Neutral |
| 2021-06-22 | Aggiornamento | Macquarie | Neutral → Outperform |
| 2021-06-22 | Iniziato | Robert W. Baird | Neutral |
| 2021-06-21 | Reiterato | Needham | Buy |
| 2021-06-16 | Downgrade | BofA Securities | Neutral → Underperform |
| 2021-06-09 | Aggiornamento | CLSA | Sell → Outperform |
| 2021-05-21 | Aggiornamento | JP Morgan | Neutral → Overweight |
| 2021-05-11 | Aggiornamento | Citigroup | Neutral → Buy |
| 2021-04-30 | Downgrade | Citigroup | Buy → Neutral |
| 2021-03-16 | Aggiornamento | Needham | Hold → Buy |
| 2020-11-02 | Aggiornamento | UBS | Neutral → Buy |
| 2020-10-30 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2020-10-27 | Aggiornamento | BofA Securities | Underperform → Neutral |
| 2020-08-07 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-06-17 | Aggiornamento | Morgan Stanley | Equal-Weight → Overweight |
| 2020-05-01 | Downgrade | JP Morgan | Neutral → Underweight |
| 2020-05-01 | Aggiornamento | Oppenheimer | Perform → Outperform |
| 2020-02-18 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| 2020-02-03 | Iniziato | CLSA | Underperform |
| 2020-01-31 | Downgrade | UBS | Buy → Neutral |
| 2020-01-10 | Iniziato | Oppenheimer | Perform |
| 2019-11-22 | Iniziato | KeyBanc Capital Markets | Sector Weight |
| 2019-07-29 | Aggiornamento | UBS | Neutral → Buy |
| 2019-07-16 | Downgrade | UBS | Buy → Neutral |
| 2019-05-06 | Aggiornamento | UBS | Neutral → Buy |
| 2019-04-18 | Aggiornamento | JP Morgan | Underweight → Neutral |
| 2019-01-25 | Downgrade | Goldman | Buy → Neutral |
| 2019-01-25 | Downgrade | JP Morgan | Neutral → Underweight |
| 2018-10-26 | Aggiornamento | Credit Suisse | Neutral → Outperform |
| 2018-07-02 | Iniziato | Goldman | Buy |
Mostra tutto
Resmed Inc Borsa (RMD) Ultime notizie
Resmed director Farrell sells $520k in stock - Investing.com India
Insider Sell: Peter Farrell Sells 2,000 Shares of ResMed Inc (RM - GuruFocus
ResMed Director Peter Farrell Plans Modest Insider Share Sale Under Rule 144 - TipRanks
ResMed (NYSE:RMD) Director Peter Farrell Sells 2,000 Shares - MarketBeat
ResMed Inc. $RMD Shares Sold by Victory Capital Management Inc. - MarketBeat
Quantbot Technologies LP Reduces Stock Position in ResMed Inc. $RMD - MarketBeat
ResMed Inc. $RMD Shares Purchased by Fisher Asset Management LLC - MarketBeat
ResMed Updates CDI Count Amid Cross-Market Transfers and Buybacks - TipRanks
ResMed CFO Sandercock Sells 1,000 Shares Under Pre-Set Trading Plan - TipRanks
Insider Sell Alert: Brett Sandercock Sells Shares of ResMed Inc (RMD) - GuruFocus
ResMed Executive Files Rule 144 Notice for Routine Share Sales - TipRanks
ResMed (NYSE: RMD) CFO sells 1,000 shares in Rule 10b5-1 trade - Stock Titan
Final Trades: Toast, Disney, ServiceNow and ResMed - CNBC
Mitsubishi UFJ Asset Management Increases ResMed Stake - National Today
Elo Mutual Pension Insurance Co Raises Stock Position in ResMed Inc. $RMD - MarketBeat
Resmed’s Global Sleep Survey Reveals Sleep is One of the Top Health Priorities, but Quality Rest Remains Out of Reach - Koreabizwire
Resmed Reveals Growing Global Awareness of Sleep Health Amid Action Gap in Latest Survey Findings - Quiver Quantitative
People say sleep matters most for health, yet quality rest is rare - Stock Titan
Andra AP fonden Cuts Stake in ResMed Inc. - National Today
RMD (NYSE: RMD) broker files Rule 144 notice for 1,000 shares - Stock Titan
Sleep apnea specialist Resmed announces plans for major new distribution centre - Mugglehead Investment Magazine
ResMed Inc. (RMD) Stock Analysis: Exploring a 16% Potential Upside in the Healthcare Sector - DirectorsTalk Interviews
Andra AP fonden Cuts Stock Holdings in ResMed Inc. $RMD - MarketBeat
ResMed Inc.: The Sleep-Tech Stock You Should Not Ignore in 2026 - AD HOC NEWS
RMD PE Ratio & Valuation, Is RMD Overvalued - Intellectia AI
RMD Financials: Income Statement, Balance Sheet & Cash Flow - Stock Titan
ResMed Greenwood Hub Aims To Tighten Supply Chain And Patient Access - Sahm
Mitsubishi UFJ Asset Management Increases Stake in ResMed - National Today
Mitsubishi UFJ Asset Management Co. Ltd. Raises Holdings in ResMed Inc. $RMD - MarketBeat
Intech Investment Management LLC Has $8.57 Million Holdings in ResMed Inc. $RMD - MarketBeat
Sleep Tech Demand Fuels ResMed - AlphaStreet News
ResMed Expands Greenwood Hub As Investors Weigh Valuation And Soft Momentum - Yahoo Finance
ResMed Inc (NYSE:RMD): A Durable Dividend Stock Built on Financial Strength - ChartMill
The Bull Case For ResMed (RMD) Could Change Following New Greenwood Distribution Hub Plan – Learn Why - simplywall.st
Dakota Wealth Management Grows Stake in ResMed Inc. $RMD - MarketBeat
Is ResMed Stock A Trap Or A Missed Opportunity? - Trefis
Why I would buy ResMed and these quality blue chips now - The Motley Fool Australia
Is ResMed Stock Poised for a Rally? - Trefis
Shares of Resmed Fall 3% After Declaring Plan to Open New US Distribution Center - marketscreener.com
ResMed Inc. stock falls Tuesday, underperforms market - MarketWatch
Resmed to open new distribution center in Indiana - MassDevice
ResMed Greenwood Hub Aims To Tighten Logistics And Support Growth - simplywall.st
Braun: Resmed to build $30 million facility in Greenwood - Fox 59
ResMed Inc (RMD) Shares Gap Down to $251.69 on Feb 24 - GuruFocus
ResMed opens new distribution center in Greenwood, Indiana - TipRanks
Resmed Expands U.S. Operations with New Distribution Center in Greenwood, Indiana - marketscreener.com
Resmed (RMD) Expands U.S. Footprint with New Indiana Distributio - GuruFocus
ResMed to Open New Distribution Center in Indiana - marketscreener.com
ResMed expands US operations with new distribution center in Indiana - marketscreener.com
New Resmed hub brings 100+ jobs, speeds essential healthcare deliveries - Stock Titan
LGT Capital Partners LTD. Decreases Stock Position in ResMed Inc. $RMD - MarketBeat
Resmed Inc Azioni (RMD) Dati Finanziari
Reddito
Reddito netto
Flusso di cassa
EPS
0.50%
0.62%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):